Jianan Zhao

2.5k total citations · 1 hit paper
67 papers, 1.8k citations indexed

About

Jianan Zhao is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Jianan Zhao has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Rheumatology and 11 papers in Oncology. Recurrent topics in Jianan Zhao's work include Rheumatoid Arthritis Research and Therapies (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jianan Zhao is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jianan Zhao collaborates with scholars based in China, United States and Norway. Jianan Zhao's co-authors include Shicheng Guo, Dongyi He, Steven J. Schrodi, Ping Jiang, Jingyang Luo, Jiashun Cao, Yang Wu, Qin Zhang, Yiyang Hu and Kai Wei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Science of The Total Environment.

In The Last Decade

Jianan Zhao

65 papers receiving 1.8k citations

Hit Papers

Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosi... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
    2021 172 citations Jianan Zhao, Ping Jiang et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianan Zhao China 23 713 307 278 250 234 67 1.8k
Yingjun Zhou China 22 552 0.8× 112 0.4× 25 0.1× 360 1.4× 68 0.3× 71 1.8k
Yifu Li China 24 395 0.6× 109 0.4× 36 0.1× 82 0.3× 440 1.9× 50 1.8k
Huiping Chen China 23 558 0.8× 424 1.4× 68 0.2× 20 0.1× 117 0.5× 53 2.2k
Agata Jabłońska‐Trypuć Poland 21 555 0.8× 307 1.0× 53 0.2× 37 0.1× 89 0.4× 68 2.0k
Xinyu Yang China 25 781 1.1× 137 0.4× 26 0.1× 95 0.4× 90 0.4× 149 2.2k
Changmei Wang China 17 383 0.5× 73 0.2× 116 0.4× 110 0.4× 71 0.3× 88 1.0k
Li Tang China 21 411 0.6× 172 0.6× 66 0.2× 32 0.1× 53 0.2× 85 1.3k
Karin Thelen Germany 20 698 1.0× 332 1.1× 39 0.1× 46 0.2× 57 0.2× 36 1.8k
Xiaofei Zhao China 21 398 0.6× 191 0.6× 17 0.1× 368 1.5× 54 0.2× 99 1.5k
Haijun Ma China 24 332 0.5× 639 2.1× 24 0.1× 166 0.7× 115 0.5× 60 1.6k

Countries citing papers authored by Jianan Zhao

Since Specialization
Citations

This map shows the geographic impact of Jianan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianan Zhao more than expected).

Fields of papers citing papers by Jianan Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianan Zhao. The network helps show where Jianan Zhao may publish in the future.

Co-authorship network of co-authors of Jianan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianan Zhao. A scholar is included among the top collaborators of Jianan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianan Zhao. Jianan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jianan, et al.. (2025). Sterile Inflammation and Cell Death Pathways in Liver Ischemia-Reperfusion Injury: A Review and Perspective. Endocrine Metabolic & Immune Disorders - Drug Targets. 26. e18715303401342–e18715303401342. 3 indexed citations
2.
Li, Yang, et al.. (2025). Pharmacologic treatment of fibromyalgia: an update. Frontiers in Pharmacology. 16. 1651181–1651181. 1 indexed citations
3.
Shi, Yiming, Ping Jiang, Kai Wei, et al.. (2025). Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases. Immunity Inflammation and Disease. 13(1). e70128–e70128. 1 indexed citations
4.
Zhao, Ning, Jingxian Yang, Jianan Zhao, et al.. (2025). Triclosan Caused Oocyte Meiotic Arrest by Modulating Oxidative Stress, Organelle Dysfunctions, Autophagy, and Apoptosis in Pigs. Animals. 15(6). 802–802. 3 indexed citations
5.
Shi, Yiming, Mi Zhou, Kai Wei, et al.. (2024). Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management. Frontiers in Immunology. 15. 1409555–1409555. 16 indexed citations
6.
Zhao, Jianan, et al.. (2024). siRNA therapy in osteoarthritis: targeting cellular pathways for advanced treatment approaches. Frontiers in Immunology. 15. 1382689–1382689. 13 indexed citations
7.
Zhao, Jianan, Kai Wei, Ping Jiang, et al.. (2024). Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments. ImmunoTargets and Therapy. Volume 13. 259–271. 10 indexed citations
8.
Sun, Dandan, Jianan Zhao, Siqi Li, et al.. (2024). Delivery of nucleic acid drugs for tumor therapy: Opportunities and challenges. Fundamental Research. 5(6). 2948–2959. 6 indexed citations
9.
Zhao, Jianan, Kai Wei, Yiming Shi, et al.. (2023). Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis. Frontiers in Molecular Biosciences. 10. 1202371–1202371.
10.
Liu, Jiayu, Chuanrong Zhao, Xue Xiao, et al.. (2023). Endothelial discoidin domain receptor 1 senses flow to modulate YAP activation. Nature Communications. 14(1). 6457–6457. 19 indexed citations
11.
12.
Zhao, Jianan, Chuanrong Zhao, Juanjuan Zhu, et al.. (2023). DNMT1 mediates the disturbed flow-induced endothelial to mesenchymal transition through disrupting β-alanine and carnosine homeostasis. Theranostics. 13(13). 4392–4411. 10 indexed citations
13.
Zhao, Jianan, et al.. (2023). Elucidating a fresh perspective on the interplay between exosomes and rheumatoid arthritis. Frontiers in Cell and Developmental Biology. 11. 1177303–1177303. 7 indexed citations
14.
Zhu, Juanjuan, Chuanrong Zhao, Han Liu, et al.. (2022). Shear stress regulates the SNAP23-mediated endothelial secretion of VWF through the GPR68/PKA/vimentin mechanotransduction pathway. Biochemical and Biophysical Research Communications. 607. 166–173. 4 indexed citations
15.
Zhang, Binbin, et al.. (2022). The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. Frontiers in Endocrinology. 13. 841703–841703. 66 indexed citations
16.
Zhao, Jianan, Shicheng Guo, Steven J. Schrodi, & Dongyi He. (2022). Cuproptosis and cuproptosis–related genes in rheumatoid arthritis: Implication, prospects, and perspectives. Frontiers in Immunology. 13. 930278–930278. 89 indexed citations
17.
Zhao, Chuanrong, Qinghua Cui, Dong Wang, et al.. (2021). Vitexin inhibits APEX1 to counteract the flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences. 118(48). 37 indexed citations
18.
19.
Zhang, Binbin, Jianan Zhao, Qin Feng, et al.. (2019). Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy. 113. 108778–108778. 41 indexed citations
20.
Zhao, Jianan, et al.. (2004). PAR 10 PATTERNS OF DOSING WITH ADALIMUMAB AMONG COMMERCIALLY INSURED PATIENTS. Value in Health. 7(6). 663–663. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingjun Zhou Breakdown of academic impact, for papers by Yifu Li Breakdown of academic impact, for papers by Huiping Chen Breakdown of academic impact, for papers by Agata Jabłońska‐Trypuć Breakdown of academic impact, for papers by Xinyu Yang Breakdown of academic impact, for papers by Changmei Wang Breakdown of academic impact, for papers by Li Tang Breakdown of academic impact, for papers by Karin Thelen Breakdown of academic impact, for papers by Xiaofei Zhao Breakdown of academic impact, for papers by Haijun Ma
Rankless by CCL
2026